Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma

Published:2019-01-15 Issue:1 Volume:51 Page:300-312
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Lim Sun Min,Cho Sang Hee,Hwang In Gyu,Choi Jae Woo,Chang Hyun,Ahn Myung-Ju,Park Keon Uk,Kim Ji-Won,Ko Yoon Ho,Ahn Hee Kyung,Cho Byoung Chul,Nam Byung-Ho,Chun Sang Hoon,Hong Ji Hyung,Kwon Jung Hye,Choi Jong Gwon,Kang Eun Joo,Yun Tak,Lee Keun-Wook,Kim Joo-Hang,Kim Jin Soo,Lee Hyun Woo,Kim Min Kyoung,Jung Dongmin,Kim Ji Eun,Keam Bhumsuk,Yun Hwan Jung,Kim Sangwoo,Kim Hye Ryun

Funder

Ministry of Health and Welfare

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2018-012.pdf

Reference32 articles.

1. Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

2. Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort

3. Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1